Is there a vaccine against RSV? After nearly 60 years, many potential candidates came at the same time

Published Date: 02 Mar 2023

You may not have heard of respiratory syncytial virus (RSV). However, it killed more than 100,000 people worldwide in 2019, making it the leading cause of death among children under the age of one.

Read Full News

Latest News

Europe Wants Drug Security, but It Won’t Come Cheap

A new law and EU-wide vulnerability checks aim to end chronic medicine shortages. But reshoring production could raise prices — and reshape who gets treated.

World Cup Injuries Test Sports Medicine

World Cup injuries can end careers in an instant, forcing physicians to balance elite performance demands with the long road to a safe return.

Allergy to NSAIDs Confirmed in Only About 3 in 10 Children

Most children suspected of having an allergy to NSAIDs are not truly allergic to them, and in some, a food allergy triggered by the drug may be the real reason, warranting targeted workup.

Gaza Daily Hunt for Water Lays Bare Worsening Health Crisis

Health authorities warn that Gaza is facing an unprecedented collapse of its water and sanitation systems, with consequences that could last decades.

JAK Inhibitors Linked to Higher Cancer Risk Across IMIDs

JAK inhibitors are associated with a higher risk for malignancy than TNF inhibitors across immune-mediated inflammatory diseases, according to a meta-analysis.

JAK Inhibitor Timing Affects Zoster Vaccine Response in RA

Immediate initiation of JAK inhibitor therapy after recombinant zoster vaccination is linked to lower early immune responses than delayed initiation in patients with rheumatoid arthritis.

Todays Updates

Quizartinib Benefit in AML Limited to FLT3-Mutated Subgroup

A recent trial assesses whether the addition of quizartinib following intensive chemotherapy improves survival outcomes in older patients with previously untreated AML.

FDA Approves New ROS1 Inhibitor for NSCLC

The newly approved inhibitor is for patients who previously received another drug of the same class.

Todays Updates

Quizartinib Benefit in AML Limited to FLT3-Mutated Subgroup

A recent trial assesses whether the addition of quizartinib following intensive chemotherapy improves survival outcomes in older patients with previously untreated AML.

FDA Approves New ROS1 Inhibitor for NSCLC

The newly approved inhibitor is for patients who previously received another drug of the same class.

Latest News

A new law and EU-wide vulnerability checks aim to end chronic medicine shortages. But reshoring production could raise prices — and reshape who gets treated.

World Cup injuries can end careers in an instant, forcing physicians to balance elite performance demands with the long road to a safe return.

Most children suspected of having an allergy to NSAIDs are not truly allergic to them, and in some, a food allergy triggered by the drug may be the real reason, warranting targeted workup.

Health authorities warn that Gaza is facing an unprecedented collapse of its water and sanitation systems, with consequences that could last decades.

JAK inhibitors are associated with a higher risk for malignancy than TNF inhibitors across immune-mediated inflammatory diseases, according to a meta-analysis.

Immediate initiation of JAK inhibitor therapy after recombinant zoster vaccination is linked to lower early immune responses than delayed initiation in patients with rheumatoid arthritis.

News All Time

Immunosuppression Shows No Survival Benefit in Nephropathy

Escalating immunosuppressive therapy is not associated with improved renal or patient survival in rapidly progressive secondary IgA nephropathy, a Spanish study finds.

Patients With Dermatomyositis May Develop Heart Rate Issues

A small subset of patients — primarily women — with dermatomyositis may develop postural orthostatic tachycardia syndrome years later, a study finds.

Weighted Flare Score Predicts Organ Damage Risk in Lupus

A novel weighted flare score for systemic lupus erythematosus identifies high-risk disease flares, which are linked to the risk for subsequent organ damage.

Which Factors Affect Quality of Life in Chronic Pruritus

Daily itch duration, sleep disturbance, scratching frequency, and average itch intensity mediate the link between disease severity and quality-of-life impairment in patients with pruritic dermatoses.

Hyponatremia in Man Reveals Isolated Aldosterone Deficiency

Persistent hyponatremia despite treatment prompts further evaluation, revealing isolated aldosterone deficiency despite normal adrenal function and leading to effective therapy.

How to Spot Anxiety in General Practice

Anxiety disorders are common but often missed in primary care, and routine screening, cognitive-behavioral therapy, and collaborative care may help GPs identify and manage them earlier.

Australia Seeks to Reverse Surge in Syphilis Cases

Syphilis has reemerged as a major public health threat across Australia but signs indicate that things might be improving.

Why This Painful Disorder Can Take a Decade-Plus to Diagnose

A connective tissue disorder with wide-ranging symptoms, hypermobile Ehlers-Danlos syndrome can lead to serious complications and harm from a medical system that doesn’t understand it.

Getting Blood Into Ambulances Matters in Trauma Cases

More hospitals and EMS systems are stocking blood to begin transfusions in trauma patients. Many believe it is saving lives.

Finding the Mystery to Trigger-Induced Atrial Fibrillation

An effort to produce recommendations for hospitalists to treat atrial fibrillation led to a wide-ranging search for answers.

GSK's Jemperli Meets Main Goal in Mid-stage Rectal Cancer Trial

GSK said on Monday its cancer drug Jemperli met the primary goal of a ⁠mid-stage trial, with a clinically significant rate of patients showing no detectable signs of cancer...

Screening Reveals High Rate of EoE in Pediatric Asthma

Symptom-based screening in pediatric asthma and allergy clinics identifies a previously unrecognized high prevalence of eosinophilic esophagitis.

German Hospital Treats US Ebola Patient Infected in Congo

A U.S. citizen infected with the Ebola virus in Democratic Republic of Congo ⁠was admitted to Frankfurt University Hospital early on Monday, officials said.

Alcohol Emergencies: When Is It More Than Intoxication?

Experts outline practical strategies to recognize acute alcohol-related conditions, avoid diagnostic bias, and identify life-threatening complications in the emergency department.

A New Class of Therapeutics Could End Immunosuppressants

Amid growing evidence and a Nobel Prize win, research on regulatory T cells could transform treatment for autoimmune disease and transplant rejection, among many other conditions.

FDA Awards Breakthrough Status to Second Biologic for CLE

A faster review means there may soon be a novel therapy for the skin manifestations of lupus for the first time in a half-century.

Recommended News For You

Charles III, King of Kings, is Cancerous.

Prostate cancer 'is not a death knell': Early detection and personalized care improve outcomes, study shows

Chemicals in Sewage Sludge Fertilizer Pose Cancer Risk, EPA Says

recognizing the mechanism by which the replication of the host cell is outperformed by the skin cancer virus.

In Biochemically Recurrent Nonmetastatic Prostate Cancer, Apalutamide Presents Its Argument.

Adjunctive Cannabis Extract Improves Nausea-Vomiting Prevention in Cancer Patients

Radiation therapy can promote amphiregulin, which increases growth of metastases

Recommended Articles For You

Seeing the Unseen: Examining Chancroid Through Images 

Multiple Myeloma: Understanding the Basics  

Unlocking the Potential of Palbociclib: A Comprehensive Overview 

The Pivotal Role of Telomerase in Breast Cancer Therapy Resistance and Treatment Strategies 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Nearly 6 Million Deaths From Five Major Cancer Types Averted Since 1975

2.

Researchers Challenge USPSTF's Lung Cancer Screening Criteria

3.

Prostate cancer Q&A: Improving detection and reducing overtreatment

4.

Diet and Prostate Cancer; TTFields OK'd for NSCLC; Cancer Studies Retracted

5.

How 7,000 steps a day could help reduce your risk of cancer

1.

MASLD and Cancer Risk: Pathogenic Links and Clinical Implications Reviewed

2.

Targeted Approaches to Breast Cancer Liver Metastases: Surgery, Ablation, and Survival Insights

3.

How is Digital Innovation Revolutionizing Gynecologic Oncology Treatment and Patient Engagement?

4.

Comprehensive Applications in Oncology and Quality Improvement

5.

Apheresis vs. IVMP in Cancer Treatment: A Tale of Two Titans

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Preventing Blood Clots: The Importance of Venous Thromboembolism Management

2.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

3.

Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment

4.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV

5.

First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot